How closely do real-world prescribing patterns for Bell’s palsy align with the AAO-HNS guideline-recommended steroid and steroid–antiviral therapy?
Statistical Fragility of Steroid–Antiviral Therapy for Bell’s Palsy: A Systematic Review of RCTs
Evidence supporting the addition of antivirals to corticosteroids in Bell’s palsy is statistically fragile. Across randomized controlled trials (RCTs), only a few patient outcome reversals would nullify reported significance, suggesting current conclusions about combination therapy lack robustness.
Younger Onset Age and Early Treatment Benefit Women with Bell’s Palsy
Do the clinical features and treatment results, and the factors affecting them, differ between male and female patients with Bell’s palsy?
Pregnancy-Associated Bell’s Palsy Associated with Worse Longterm Outcomes
These poor outcomes seem to be the result of factors intrinsic to pregnancy, not the tendency for medical therapy to be withheld in pregnancy-associated cases of BP.
